IDEAS home Printed from https://ideas.repec.org/p/chy/respap/143chedp.html
   My bibliography  Save this paper

Valuing health states: the effect of duration

Author

Listed:
  • Claire Gudex
  • Paul Dolan

Abstract

A central task in the field of health status measurement involves eliciting valuations for health states. When these valuations are then used in estimating patient benefit as part of a cost-utility analysis, a key issue is how the duration of a health state affects its value. Previous studies suggest that while people adapt to chronic illness over time there is a “maximal endurable time” beyond which the state becomes intolerable. The pilot study reported here examines the feasibility of using the visual analogue scale method to elicit within-respondent valuations for health states of different durations. It explores the hypothesis that while less severe states are seen as more acceptable the longer they last, more severe health states are seen as increasingly intolerable. 18 members of the general population ranked and rated 15 health states with durations of 1 month, 1 year and 10 years. The valuation given to a health state appeared to be a function of both its severity and its duration. The median score for a state lasting 10 years was lower when the same state lasted for 1 year or 1 month, supporting the concept of a “maximal endurable time”. Valuations for mild states did not, however, increase with duration.

Suggested Citation

  • Claire Gudex & Paul Dolan, 1995. "Valuing health states: the effect of duration," Working Papers 143chedp, Centre for Health Economics, University of York.
    • Handle: RePEc:chy:respap:143chedp
    as

    Download full text from publisher

    File URL: http://www.york.ac.uk/media/che/documents/papers/discussionpapers/CHE%20Discussion%20Paper%20143.pdf
    File Function: First version, 1995
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. George W. Torrance & Michael H. Boyle & Sargent P. Horwood, 1982. "Application of Multi-Attribute Utility Theory to Measure Social Preferences for Health States," Operations Research, INFORMS, vol. 30(6), pages 1043-1069, December.
    2. Stephen J Wright, 1986. "Age, sex and health: a summary of findings from the York Health Evaluation Survey," Working Papers 015chedp, Centre for Health Economics, University of York.
    3. J. Leighton Read & Robert J. Quinn & Donald M. Berwick & Harvey V. Fineberg & Milton C. Weinstein, 1984. "Preferences for Health Outcomes," Medical Decision Making, , vol. 4(3), pages 315-329, August.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. N J Devlin & P Hansen & P Kind & A H Williams, 2000. "The health state preferences and logistical inconsistencies of New Zealanders: a tale of two tariffs," Working Papers 180chedp, Centre for Health Economics, University of York.
    2. Nancy J. Devlin & Paul Hansen & Paul Kind & Alan Williams, 2003. "Logical inconsistencies in survey respondents' health state valuations ‐ a methodological challenge for estimating social tariffs," Health Economics, John Wiley & Sons, Ltd., vol. 12(7), pages 529-544, July.
    3. Irina Cleemput, 2010. "A social preference valuations set for EQ-5D health states in Flanders, Belgium," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 11(2), pages 205-213, April.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. David Parkin & Nancy Devlin, 2006. "Is there a case for using visual analogue scale valuations in cost‐utility analysis?," Health Economics, John Wiley & Sons, Ltd., vol. 15(7), pages 653-664, July.
    2. Raisa B. Deber & Vivek Goel, 1990. "Using Explicit Decision Rules to Manage Issues of Justice, Risk, and Ethics in Decision Analysis," Medical Decision Making, , vol. 10(3), pages 181-194, August.
    3. Nick Bansback & Huiying Sun & Daphne P. Guh & Xin Li & Bohdan Nosyk & Susan Griffin & Paul G. Barnett & Aslam H. Anis, 2008. "Impact of the recall period on measuring health utilities for acute events," Health Economics, John Wiley & Sons, Ltd., vol. 17(12), pages 1413-1419.
    4. Gordon Hazen, 2004. "Multiattribute Structure for QALYs," Decision Analysis, INFORMS, vol. 1(4), pages 205-216, December.
    5. Zhang, Tianyu & Dong, Peiwu & Zeng, Yongchao & Ju, Yanbing, 2022. "Analyzing the diffusion of competitive smart wearable devices: An agent-based multi-dimensional relative agreement model," Journal of Business Research, Elsevier, vol. 139(C), pages 90-105.
    6. Anirban Basu & William Dale & Arthur Elstein & David Meltzer, 2009. "A linear index for predicting joint health‐states utilities from single health‐states utilities," Health Economics, John Wiley & Sons, Ltd., vol. 18(4), pages 403-419, April.
    7. Cathleen Mooney & Alvin I. Mushlin & Charles E. Phelps, 1990. "Targeting Assessments of Magnetic Resonance Imaging in suspected Multiple sclerosis," Medical Decision Making, , vol. 10(2), pages 77-94, June.
    8. Zanakis, Stelios H. & Mandakovic, Tomislav & Gupta, Sushil K. & Sahay, Sundeep & Hong, Sungwan, 1995. "A review of program evaluation and fund allocation methods within the service and government sectors," Socio-Economic Planning Sciences, Elsevier, vol. 29(1), pages 59-79, March.
    9. Lee, Jonq-Ying & Rampersaud, Gail S. & Brown, Mark G., 2008. "An Index to Measure Health Status," Research papers 36819, Florida Department of Citrus.
    10. Han Bleichrodt, 2002. "A new explanation for the difference between time trade‐off utilities and standard gamble utilities," Health Economics, John Wiley & Sons, Ltd., vol. 11(5), pages 447-456, July.
    11. Hammer, Jeffrey S., 1992. "To prescribe or not to prescribe: On the regulation of pharmaceuticals in less developed countries," Social Science & Medicine, Elsevier, vol. 34(9), pages 959-964, May.
    12. Alan Shiell & Lisa Gold, 2003. "If the price is right: vagueness and values clarification in contingent valuation," Health Economics, John Wiley & Sons, Ltd., vol. 12(11), pages 909-919, November.
    13. William B. Haskell & Wenjie Huang & Huifu Xu, 2018. "Preference Elicitation and Robust Optimization with Multi-Attribute Quasi-Concave Choice Functions," Papers 1805.06632, arXiv.org.
    14. San Miguel, Fernando & Ryan, Mandy & Scott, Anthony, 2002. "Are preferences stable? The case of health care," Journal of Economic Behavior & Organization, Elsevier, vol. 48(1), pages 1-14, May.
    15. George W. Torrance & David Feeny & William Furlong, 2001. "Visual Analog Scales," Medical Decision Making, , vol. 21(4), pages 329-334, August.
    16. Busschbach, Jan J. V. & McDonnell, Joseph & Essink-Bot, Marie-Louise & van Hout, Ben A., 1999. "Estimating parametric relationships between health description and health valuation with an application to the EuroQol EQ-5D," Journal of Health Economics, Elsevier, vol. 18(5), pages 551-570, October.
    17. Alan Shiell & Janelle Seymour & Penelope Hawe & Sue Cameron, 2000. "Are preferences over health states complete?," Health Economics, John Wiley & Sons, Ltd., vol. 9(1), pages 47-55, January.
    18. Andrew Grant & Steve Satchell, 2019. "Endogenous divorce risk and investment," Journal of Population Economics, Springer;European Society for Population Economics, vol. 32(3), pages 845-876, July.
    19. Brazier, John & Roberts, Jennifer & Deverill, Mark, 2002. "The estimation of a preference-based measure of health from the SF-36," Journal of Health Economics, Elsevier, vol. 21(2), pages 271-292, March.
    20. Ubel, Peter A. & Loewenstein, George & Scanlon, Dennis & Kamlet, Mark, 1998. "Value measurement in cost-utility analysis: explaining the discrepancy between rating scale and person trade-off elicitations," Health Policy, Elsevier, vol. 43(1), pages 33-44, January.

    More about this item

    Keywords

    health state valuation;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:chy:respap:143chedp. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Gill Forder (email available below). General contact details of provider: https://edirc.repec.org/data/chyoruk.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.